MAPK1 and lung carcinoma: Consistent with previous findings in other cell types (Sanders and Basson, 2000; Schmitz et al, 2005; Vulin et al, 2005; Stulic et al, 2007), we found an enhanced activation of Src, ERK, PI3K, and Akt in A549 lung cancer cells.